for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis.
(including acarbose and miglitol) delay breakdown of carbohydrates in the small intestine, and lower postprandial glucose and insulin levels.
Alternative Agents in Type 1 Diabetes in Addition to Insulin Therapy Metformin, Alpha-Glucosidase Inhibitors
, Pioglitazone, GLP-1 Agonists, DPP-IV Inhibitors, and SGLT-2 Inhibitors.
Schnell, "Alpha-glucosidase inhibitors
2012--cardiovascular considerations and trial evaluation," Diabetes and Vascular Disease Research, vol.
Inoue, Effect of two alpha-glucosidase inhibitors
, voglibose and acarbose, on postprandial hyperglycemia correlates with subjective abdominal symptoms, Metabolism, 54, (2005).
Effect of acarbose, an alpha-glucosidase inhibitor
, on serum lipoprotein lipase mass levels and common carotid artery intima-media thickness in type 2 diabetes mellitus treated by sulfonylurea.
It is believed that one possible mechanism for basil's blood glucose lowering effect is ursolic acid, which has been shown to act as an alpha-glucosidase inhibitor
, meaning it reduces the absorption of glucose in the small intestine and prevents a rise in blood sugar levels.
Safe and effective treatment of diabetes mellitus associated with chronic liver diseases with an alpha-glucosidase inhibitor
Physicians offer the package to patients when they receive new prescriptions for the alpha-glucosidase inhibitor
, which debuted in January 1996.
Sulfonylurea therapy in combination with the biguanide, metformin (Glucophage[R]) or in combination with the alpha-glucosidase inhibitor
, acarbose (Precose[R]) is frequently used.
He and his associates are beginning a randomized trial of acarbose plus diet versus diet alone in 200 women with gestational diabetes to see whether the alpha-glucosidase inhibitor
can reduce the number of women who need insulin or glyburide therapy
Body weight reduction effect of an alpha-glucosidase inhibitor
, acarbose - comparison within South Asian countries.
The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor
to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data.
By drug class, the global diabetes drug market has been segmented into insulin, sensitizers, alpha-glucosidase inhibitors
, SGLT-2 inhibitors, secretagogues, peptide analogs, and others.
Lebovitz, Alpha-glucosidase inhibitors